3
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Infliximab in the treatment of psoriasis

&
Pages 515-526 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gino A Vena & Nicoletta Cassano. (2007) Anti-tumor necrosis factor therapies for psoriasis. Expert Review of Dermatology 2:3, pages 335-349.
Read now

Articles from other publishers (4)

L. Puig, E. Sáez, M.J. Lozano, X. Bordas, J.M. Carrascosa, F. Gallardo, J. Luelmo, M. Sánchez-Regaña, M. Alsina & V. García-Patos. (2009) Reacciones a la infusión de infliximab en pacientes dermatológicos. Actas Dermo-Sifiliográficas 100:2, pages 103-112.
Crossref
L. Puig, E. Sáez, M.J. Lozano, X. Bordas, J.M. Carrascos, F. Gallardo, J. Luelmo, M. Sánchez-Regaña, M. Alsina & V. García-Patos. (2009) Reactions to Infliximab Infusions in Dermatologic Patients: Consensus Statement and Treatment Protocol. Actas Dermo-Sifiliográficas (English Edition) 100:2, pages 103-112.
Crossref
Rotraut Mössner, Michael P. Schön & Kristian Reich. (2008) Tumor necrosis factor antagonists in the therapy of psoriasis. Clinics in Dermatology 26:5, pages 486-502.
Crossref
Kristian Reich & Ulrich Mrowietz. (2007) Treatment goals in psoriasis. JDDG 5:7, pages 566-574.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.